concept

GSK3β

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about GSK3β: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

28Connections
2Hypotheses
3Analyses
11Outgoing
17Incoming
0Experiments
3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameGSK3β
Key Genes/ProteinsAkt, AKT, APP, CLCN1, phospho-tau, PI3K
Related Diseasesneurodegeneration
Related PathwaysNF-κB
Linked Hypotheses2 hypotheses

Wiki Pages (1)

Knowledge base pages for this entity

GSK3β (Glycogen Synthase Kinase 3 Beta) Neurons

cell · 590 words

Pathway Diagram

graph TD
    GSK3_["GSK3beta"]
    GSK3_ -->|"activates"| Tau_hyperphosphorylation["Tau hyperphosphorylation"]
    GSK3_ -->|"activates"| phospho_tau["phospho-tau"]
    GSK3_ -->|"regulates"| Tau["Tau"]
    GSK3_ -->|"inhibits"| PP2A["PP2A"]
    GSK3_ -->|"activates"| PTEN["PTEN"]
    AKT["AKT"] -->|"phosphorylates"| GSK3_
    CLCN1["CLCN1"] -->|"interacts"| GSK3_
    PI3K["PI3K"] -->|"inhibits"| GSK3_
    Akt["Akt"] -->|"regulates"| GSK3_
    exercise["exercise"] -->|"inhibits"| GSK3_
    NRF2["NRF2"] -->|"inhibits"| GSK3_

Outgoing (11)

TargetRelationTypeStr
h-373fac84b5targeted_byhypothesis1.00
tauassociated_withprotein0.90
α-Synuclein Pathologymodulatesprocess0.80
Complement C3/C3Ar Pathwayinvolved_inpathway0.75
PP2Ainhibitsprotein0.70

Incoming (17)

SourceRelationTypeStr
h-373fac84b5targetshypothesis1.00
AKTphosphorylatesprotein0.90
PI3Kpart_ofgene0.90
AKTinhibitsgene0.80
PI3Kinteracts_withgene0.80

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
MAP6-CRMPS cooperative phosphorylation by GSK3β 0.700 neurodegeneration View
GSK3β Inhibition to Prevent α-Synuclein Phosphorylation and 0.429 neurodegeneration Does RGS6 upregulation or D2 autorecepto

Mentioning Analyses (3)

Scientific analyses that reference this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.585

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

neurodegeneration | 2026-04-17 | 7 hypotheses Top: 0.559

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation,

closed · Rounds: 4 · Score: 0.92 · 2026-04-16

Related Research

Hypotheses and analyses mentioning GSK3β in their description or question text

No additional research found